The Technical AnalystExchange: NSE Sector: Healthcare Industry: Drug Manufacturers—General
Kopran Limited Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.05% INR240.75
America/New_York / 8 mai 2024 @ 02:45
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 11 607 mill |
| EPS: | 8.37 |
| P/E: | 28.76 |
| Earnings Date: | May 23, 2024 |
| SharesOutstanding: | 48.21 mill |
| Avg Daily Volume: | 0.443 mill |
| RATING 2024-05-08 |
|---|
| B+ |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Buy | |
| Return On Asset: | Neutral | |
| DE: | Sell | |
| P/E: | Buy | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | n/a | n/a | n/a | |||
| Debt | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 28.76 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 28.76 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
INR-144.76 (-160.13%) INR-385.51 |
| Date: 2024-05-07 |
| Expected Trading Range (DAY) |
|---|
|
INR 227.92 - 254.08 ( +/- 5.43%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | INR240.75 (1.05% ) |
| Volume | 0.0811 mill |
| Avg. Vol. | 0.443 mill |
| % of Avg. Vol | 18.30 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For KOPRAN.NS
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
KOPRAN.NS
Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai, India.